/Investor DB

Parkwalk Advisors — 2024 Investments

6 investments dated 2024 · listed companies and verified rows first · show all

Adsilicoadsilico.ukFeb 2024

adsilico builds generative AI technology that creates diverse virtual patient populations—digital models of human anatomy, physiology, and pathology—to run in silico trials that assess medical device safety and performance before human testing.

AI & Machine LearningHealthtechMedical Devices

Dr Nishant RavikumarinDr Zeike TaylorinProf Alejandro FrangiSheena Macphersonin

Co-investorsNorthern Gritstone

Alunalun.com.brMay 2024

Alun is a Brazilian education group offering programs in technology, business, and artificial intelligence, spanning a tech-focused college, a digital products and business school, an executive development platform, and corporate training.

AI & Machine LearningEdTechFuture of Work

Co-investorsCrescera CapitalVulpes Investment Management

Echopoint Medicalechopointmedical.comin𝕏Series A · May 2024 · $5M

Echopoint Medical develops cardiac technology focused on coronary physiology for interventional cardiology.

Deep TechHardwareHealthtechMedical DevicesLondon, GB

Antony Odell(CEO & co-Founder)inMalcolm Finlay(CMO & Co-founder)inAdrien Desjardins(CSO & Co-Founder)inPriscila Hancock(Executive Officer)Nijs van de Vaart(COO)inPri Hancock(CFO)in

Co-investorsUCL Technology FundQueen Mary University of LondonAlbionVCNew Wave Ventures

Legislatelegislate.ai𝕏Jan 2024 · $3.6M

TextMine automates data extraction from business-critical documents using AI, serving enterprises in financial services, legal, and technology sectors that require high accuracy and security in document processing workflows.

AI & Machine LearningFintechLegalTechSaaSLondon, GB

Charles BrecqueinMary Catherine Di Nunzio(CLO)inMary Catherine(Chief Legal Officer)

Co-investorsOxfordPerivoli Innovations

PhoreMost Limitedphoremost.comin𝕏Seed · Sep 2024 · $4M

PhoreMost is a biotechnology company developing small molecule drugs and targeted protein degradation therapeutics for cancers with high unmet clinical need, with a lead program (PMC-001) for primary and metastatic brain cancers in Phase 1/2a clinical evaluation.

BiotechMedical DevicesCambridge, GB

Co-investorsAmadeus Capital PartnersAstellas Venture Management LLCCambridge Angels groupUniversity of Cambridge EnterpriseAmadeus Capital SAO2h Ventures

xWattsxwatts.coinJul 2024

xWatts is an intelligent energy management platform that connects to building energy systems, models facilities in real time, and automatically optimizes assets like HVAC, solar, and CHP engines to reduce energy costs and emissions in large, complex estates and industrial facilities.

CleantechClimate TechEnergyEnterprise SoftwarePropTech

Yigit Akar(Co-founder & CEO)inAlex Allen(Co-founder & CPO)Alexander A.(Founder)in

Co-investorsAntlerR42 GroupCambridge Angels groupPlug and Play Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.